Bendamustine Synthesis Using Glutaric Anhydride and 2-Haloethanols

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing Bendamustine suffer from low yields, formation of by-products, and the use of toxic and explosive gases like ethylene oxide, making them unsuitable for large-scale industrial processes and posing occupational safety concerns.

Innovation Solution

A method involving the conversion of 2-fluoro-5-nitroaniline to 4-(1-methyl-5-nitrobenzimidazol-2-yl)butanoic acid using glutaric anhydride, followed by subsequent steps without isolation of intermediates, utilizing inert solvents and catalysts like palladium doped with iron to enhance yield and safety, and avoiding the use of hazardous gases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing methods for producing Bendamustine are used, then the synthesis can be completed, but the yield is low and by-products are formed

Engineering Contradiction:
ImproveyieldVSAvoidpurity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes by optimizing reaction conditions including pH control (maintaining pH 4.0-6.0 using acetate buffer), temperature control (50-80°C), and molar ratios of reactants. These parameter optimizations resolve the contradiction by achieving both high yield (76%) and high purity through precise control of the alkylation reaction conditions

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses an acetate buffer system as an intermediary to control the reaction environment. The buffer maintains optimal pH conditions during the alkylation reaction, preventing side reactions that would form by-products while ensuring complete conversion of the starting material, thus simultaneously improving yield and purity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If ethylene oxide is used during the synthesis, then the alkylation reaction can proceed, but toxic and explosive gas is introduced creating occupational safety concerns

Engineering Contradiction:
ImprovereactivityVSAvoidtoxicity
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the hazardous ethylene oxide gas with 2-haloethanols (such as 2-chloroethanol or 2-bromoethanol), which are stable liquid reagents. These alternative reagents provide the necessary alkylation functionality without the toxic and explosive properties of ethylene oxide, eliminating occupational safety concerns while maintaining reaction effectiveness

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent converts the harmful gaseous reagent into a beneficial liquid alternative that maintains the desired chemical reactivity. By using 2-haloethanols instead of ethylene oxide, the process achieves the same alkylation purpose while eliminating the harmful effects, effectively turning a potentially dangerous process into a safe one

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Ease of manufacture

If the favoured procedure using Hünig's base is used, then the alkylation can be performed, but the yield is not greater than 44.5% and purity is 97.6%

Engineering Contradiction:
ImproveprocessabilityVSAvoidyield
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent achieves superior yield (76%) by changing key reaction parameters: using acetate buffer instead of Hünig's base for pH control, operating at lower temperatures (50-80°C vs higher temperatures), and using 2-haloethanols instead of other alkylating agents. These parameter changes resolve the contradiction by maintaining processability while dramatically improving productivity

Inventive Principle:
Principle #35Parameter changes

4Productivity

If some reaction steps are performed in large scale or industrial processes, then production volume increases, but the process becomes difficult to implement due to safety and yield issues

Engineering Contradiction:
Improveproduction volumeVSAvoidsafety
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent replaces hazardous reagents with safe alternatives that are suitable for industrial scale-up. By using stable liquid 2-haloethanols instead of explosive ethylene oxide gas, and using buffered aqueous systems, the process becomes reliable and safe for large-scale production while maintaining high productivity

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent creates a safe reaction environment by using aqueous acetate buffer systems and avoiding hazardous gases. This inert-like environment eliminates occupational safety concerns and makes the process suitable for industrial implementation at any scale, resolving the contradiction between production volume and safety

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly increases yields to 76% compared to previous methods, reduces by-product formation, and eliminates the use of toxic gases, making the process more economical and safer for industrial-scale production.

Implementation Method 1

utilizing inert solvents and catalysts like palladium doped with iron to enhance yield and safety

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

2-fluoro-5-nitroaniline is converted to 5-(2-fluoro-5-nitroanilino)-5-oxopentanoic acid (1, CAS No 451459-95-3) using glutaric anhydride

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentUS8987469B2Process for the preparation of bendamustine
Publication Date: 2015.03.24 HEYL CHEM PHARMA FAB GMBH & CO KG
  • US8987469B2 patent drawing
  • US8987469B2 patent drawing
  • US8987469B2 patent drawing

AI summary

The present invention relates to a method for preparation of alkyl 4-[5-[bis(2 -hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl]butanoate (7) from 2-fluoro-5-nitroaniline, comprising the steps of: (a) conversion of 2-fluoro-5-nitroaniline to 5-(2-fluoro-5-nitroanilino)-5 -oxopentanoic acid (1) using glutaric anhydride, conversion of compound (1) to methylammonium 5-[2-(methylamino)-5-nitroanilino]-5-oxopentanoate (2) using methylamine; conversion of compound (2) to 5[2-(methylamino)-5-nitroanilino]-5-oxopentanoic acid (3) and condensation of compound (3) to 4-(1-methyl-5-nitro-1H-benzimidazol-2-yl)butanoic acid (4); (b) esterification of the product (4) of step a) to alkyl 4-(1-methyl-5-nitro 1H-benzimidazol-2-yl)butanoate (5); (c) reduction of the product of step b) to alkyl 4-(5-amino-l-methyl-1H-benzimidazol-2-yl)butanoate (6), and (d) conversion of the product of step c) to alkyl 4-[5-[bis(2-hydroxyethyl)amino]-1-methyl -1H-benzimidazol-2-yl]butanoate (7).